The interaction of HA and CD44 promotes EGFR-mediated pathways, consequently leading to tumor cell growth, tumor cell migration, and chemotherapy resistance in breast, prostate, and gastrointestinal cancers (100). The gene discussed is EGFR; the disease is neoplasm.